GB9811854D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9811854D0
GB9811854D0 GBGB9811854.0A GB9811854A GB9811854D0 GB 9811854 D0 GB9811854 D0 GB 9811854D0 GB 9811854 A GB9811854 A GB 9811854A GB 9811854 D0 GB9811854 D0 GB 9811854D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9811854.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Priority to GBGB9811854.0A priority Critical patent/GB9811854D0/en
Publication of GB9811854D0 publication Critical patent/GB9811854D0/en
Priority to HU0102142A priority patent/HUP0102142A3/hu
Priority to PL99344451A priority patent/PL344451A1/xx
Priority to KR1020007013585A priority patent/KR20010043969A/ko
Priority to AU43724/99A priority patent/AU750422B2/en
Priority to CN99806904A priority patent/CN1304315A/zh
Priority to IL13958999A priority patent/IL139589A0/xx
Priority to IDW20002433A priority patent/ID27576A/id
Priority to SK1814-2000A priority patent/SK18142000A3/sk
Priority to PCT/EP1999/003770 priority patent/WO1999062540A1/en
Priority to JP2000551796A priority patent/JP4523154B2/ja
Priority to EP99926489A priority patent/EP1082130A1/en
Priority to CA002333315A priority patent/CA2333315A1/en
Priority to BR9910860-7A priority patent/BR9910860A/pt
Priority to TW088109078A priority patent/TWI250022B/zh
Priority to TW094110378A priority patent/TWI250021B/zh
Priority to ZA200006464A priority patent/ZA200006464B/en
Priority to NO20006113A priority patent/NO20006113L/no
Priority to JP2009252882A priority patent/JP2010059177A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB9811854.0A 1998-06-02 1998-06-02 Organic compounds Ceased GB9811854D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB9811854.0A GB9811854D0 (en) 1998-06-02 1998-06-02 Organic compounds
BR9910860-7A BR9910860A (pt) 1998-06-02 1999-05-31 Uso de ciclosporinas no tratamento de doenças auto-imunes inflamatórias
SK1814-2000A SK18142000A3 (sk) 1998-06-02 1999-05-31 Použitie cyklosporínov na liečenie zápalových autoimunitných ochorení
JP2000551796A JP4523154B2 (ja) 1998-06-02 1999-05-31 炎症性自己免疫疾患の処置におけるサイクロスポリン類の使用
KR1020007013585A KR20010043969A (ko) 1998-06-02 1999-05-31 염증성 자기면역 질환의 치료에서 사이클로스포린의 용도
AU43724/99A AU750422B2 (en) 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
CN99806904A CN1304315A (zh) 1998-06-02 1999-05-31 环孢菌素类化合物在治疗炎症性自身免疫疾病中的用途
IL13958999A IL139589A0 (en) 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
IDW20002433A ID27576A (id) 1998-06-02 1999-05-31 Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
HU0102142A HUP0102142A3 (en) 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
PCT/EP1999/003770 WO1999062540A1 (en) 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
PL99344451A PL344451A1 (en) 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
EP99926489A EP1082130A1 (en) 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
CA002333315A CA2333315A1 (en) 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
TW094110378A TWI250021B (en) 1998-06-02 1999-06-01 Pharmaceutical composition for use in the treatment of an inflammatory autoimmune disease or condition
TW088109078A TWI250022B (en) 1998-06-02 1999-06-01 Pharmaceutical composition for use in the treatment of an inflammatory autoimmune disease or condition
ZA200006464A ZA200006464B (en) 1998-06-02 2000-11-09 Use of cyclosporins in the treatment of inflammatory autoimmune diseases.
NO20006113A NO20006113L (no) 1998-06-02 2000-12-01 Anvendelse av cyklosporiner i behandlingen av inflammatoriske autoimmune sykdommer
JP2009252882A JP2010059177A (ja) 1998-06-02 2009-11-04 炎症性自己免疫疾患の処置におけるサイクロスポリン類の使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9811854.0A GB9811854D0 (en) 1998-06-02 1998-06-02 Organic compounds

Publications (1)

Publication Number Publication Date
GB9811854D0 true GB9811854D0 (en) 1998-07-29

Family

ID=10833083

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9811854.0A Ceased GB9811854D0 (en) 1998-06-02 1998-06-02 Organic compounds

Country Status (17)

Country Link
EP (1) EP1082130A1 (zh)
JP (2) JP4523154B2 (zh)
KR (1) KR20010043969A (zh)
CN (1) CN1304315A (zh)
AU (1) AU750422B2 (zh)
BR (1) BR9910860A (zh)
CA (1) CA2333315A1 (zh)
GB (1) GB9811854D0 (zh)
HU (1) HUP0102142A3 (zh)
ID (1) ID27576A (zh)
IL (1) IL139589A0 (zh)
NO (1) NO20006113L (zh)
PL (1) PL344451A1 (zh)
SK (1) SK18142000A3 (zh)
TW (2) TWI250022B (zh)
WO (1) WO1999062540A1 (zh)
ZA (1) ZA200006464B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030379A2 (en) 1999-10-27 2001-05-03 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
US7419670B2 (en) * 2000-09-29 2008-09-02 Viron Therapeutics, Inc. Method of treating arthritis with SERP-1 and an immunosuppressant
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
BRPI0509690A (pt) * 2004-04-08 2007-10-09 Novartis Ag nim811 na isquemia cerebral e danos cerebrais e na medula espinhal
ATE497775T1 (de) 2004-07-14 2011-02-15 Novartis Pharma Gmbh Verwendung einer kombination von cyclosporin und pegylierten interferonen zur behandlung von hepatitis c (hcv)
UA88484C2 (ru) * 2004-10-01 2009-10-26 Дебиофарм Са ПРИМЕНЕНИЕ [D-MeAla]3-[EtVal]4-ЦИКЛОСПОРИНА ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИИ ГЕПАТИТА С И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ ВКЛЮЧАЕТ [D-MeAla]3-[EtVal]4-ЦИКЛОСПОРИН
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
KR20070087624A (ko) 2004-12-23 2007-08-28 노파르티스 아게 Ｈｃｖ 치료용 조성물
KR20070089954A (ko) * 2004-12-23 2007-09-04 노파르티스 아게 플라비비리대 치료용 화합물
AR054778A1 (es) 2005-06-17 2007-07-18 Novartis Ag Uso de sangliferina en hcv
JP2007112775A (ja) * 2005-10-24 2007-05-10 Hamamatsu Univ School Of Medicine サイトメガロウイルス感染の処置におけるシクロスポリン類の使用
US20090306033A1 (en) * 2008-06-06 2009-12-10 Keqiang Li Novel cyclic peptides
JP5820722B2 (ja) * 2008-06-06 2015-11-24 スシネキス インク シクロスポリン類似体及びｈｃｖ感染の治療におけるその使用
CN102307892A (zh) 2008-12-31 2012-01-04 西尼克斯公司 环孢菌素a的衍生物
US20110144005A1 (en) * 2009-12-09 2011-06-16 Scynexis, Inc. Novel cyclic peptides
WO2014049540A2 (en) 2012-09-29 2014-04-03 Novartis Ag Cyclic peptides and use as medicines
EP2908841A4 (en) * 2012-10-19 2016-05-25 Scynexis Inc NEW ANTIVIRAL MACROCYCLES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69124459T3 (de) * 1990-11-02 2001-05-31 Novartis Ag, Basel Zyklosporine
US6124453A (en) * 1995-07-04 2000-09-26 Novartis Ag Macrolides
AR006514A1 (es) * 1995-07-04 1999-09-08 Sandoz Ag Un macrolido, sus usos, un proceso para producirlo, un aislado biologicamente puro capaz de producirlo, y una composicion farmaceutica quelo comprende
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
TWI250021B (en) 2006-03-01
SK18142000A3 (sk) 2001-06-11
IL139589A0 (en) 2002-02-10
EP1082130A1 (en) 2001-03-14
TWI250022B (en) 2006-03-01
WO1999062540A1 (en) 1999-12-09
AU4372499A (en) 1999-12-20
CN1304315A (zh) 2001-07-18
ZA200006464B (en) 2002-03-11
ID27576A (id) 2001-04-12
PL344451A1 (en) 2001-11-05
CA2333315A1 (en) 1999-12-09
JP2010059177A (ja) 2010-03-18
KR20010043969A (ko) 2001-05-25
NO20006113D0 (no) 2000-12-01
TW200522975A (en) 2005-07-16
HUP0102142A2 (hu) 2001-11-28
BR9910860A (pt) 2001-03-06
AU750422B2 (en) 2002-07-18
JP4523154B2 (ja) 2010-08-11
JP2002516873A (ja) 2002-06-11
NO20006113L (no) 2001-01-25
HUP0102142A3 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
GB9802251D0 (en) Organic compounds
GB9811854D0 (en) Organic compounds
GB9802725D0 (en) Organic compounds
GB9802249D0 (en) Organic compounds
GB9804265D0 (en) Organic compounds
GB9802355D0 (en) Organic compounds
GB9800520D0 (en) Organic compounds
GB9800316D0 (en) Organic compounds
GB9802842D0 (en) Organic compounds
GB9803324D0 (en) Organic compounds
GB9802450D0 (en) Organic compounds
GB9802356D0 (en) Organic compounds
GB9803904D0 (en) Organic compounds
GB9802354D0 (en) Organic compounds
GB9802252D0 (en) Organic compounds
GB9803905D0 (en) Organic compounds
GB9802250D0 (en) Organic compounds
GB9804577D0 (en) Organic compounds
GB9801866D0 (en) Organic compounds
GB9801539D0 (en) Organic compounds
GB9801469D0 (en) Organic compounds
GB9801206D0 (en) Organic compounds
GB9800701D0 (en) Organic compounds
GB9800522D0 (en) Organic compounds
GB9806290D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)